These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32776618)

  • 1. Reprogramming of antibiotics to combat antimicrobial resistance.
    Dubey KK; Indu ; Sharma M
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
    Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
    Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
    Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
    Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy: the propitious rationale for drug development.
    Phougat N; Khatri S; Singh A; Dangi M; Kumar M; Dabur R; Chhillar AK
    Comb Chem High Throughput Screen; 2014 Jan; 17(1):53-67. PubMed ID: 24138510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination approaches to combat multidrug-resistant bacteria.
    Worthington RJ; Melander C
    Trends Biotechnol; 2013 Mar; 31(3):177-84. PubMed ID: 23333434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
    Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
    Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Antimicrobial Resistance (AMR) and Alternative Approaches to Overcome AMR.
    Moo CL; Yang SK; Yusoff K; Ajat M; Thomas W; Abushelaibi A; Lim SH; Lai KS
    Curr Drug Discov Technol; 2020; 17(4):430-447. PubMed ID: 30836923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria.
    Kirienko NV; Rahme L; Cho YH
    Front Cell Infect Microbiol; 2019; 9():343. PubMed ID: 31681623
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens.
    Chen C; Shi J; Wang D; Kong P; Wang Z; Liu Y
    Crit Rev Microbiol; 2024 May; 50(3):267-284. PubMed ID: 36890767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting antibiotic resistance.
    Martínez JL; Baquero F; Andersson DI
    Nat Rev Microbiol; 2007 Dec; 5(12):958-65. PubMed ID: 18007678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial resistance and dissemination of multidrug resistant organisms-A review].
    Wang J; Wang X; Xu H
    Wei Sheng Wu Xue Bao; 2016 Nov; 56(11):1671-9. PubMed ID: 29741829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing bioactive compounds for treating multidrug-resistant pathogens.
    Hummell NA; Kirienko NV
    J Med Microbiol; 2020 Jun; 69(6):881-894. PubMed ID: 32163353
    [No Abstract]   [Full Text] [Related]  

  • 17. Antisense RNA regulation and application in the development of novel antibiotics to combat multidrug resistant bacteria.
    Ji Y; Lei T
    Sci Prog; 2013; 96(Pt 1):43-60. PubMed ID: 23738437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
    Annunziato G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
    Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
    Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies to combat antibiotic resistance.
    Brooks BD; Brooks AE
    Adv Drug Deliv Rev; 2014 Nov; 78():14-27. PubMed ID: 25450262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.